Biondvax pharmaceuticals ltd. (BVXV)
Balance Sheet / Quarterly
Dec'17
Assets
CURRENT ASSETS:
Cash and cash equivalents

20,589

Marketable securities

0

Short-term deposits

0

Other receivables

1,131

Current assets

21,720

LONG-TERM ASSETS:
Marketable securities

0

Property, plant and equipment

1,589

Other long term assets

254

Non-current assets

1,843

Total assets

23,563

Equity and Liabilities
Liabilities
CURRENT LIABILITIES:
Trade payables

1,795

Other payables

190

Current liabilities

1,985

LONG-TERM LIABILITIES:
Liability in respect of government grants

2,971

Warrants

2,358

Severance pay liability, net

24

Long-term liabilities

5,353

SHAREHOLDERS' EQUITY:-
Ordinary shares of NIS 0.0000001 par value: Authorized: 391,000,000 shares as of December 31, 2017; Issued and Outstanding: 261,419,599, 135,097,367, shares as of December 31, 2017 and December 31, 2016, respectively

0

Share premium

51,823

Options

0

Other comprehensive income

0

Accumulated deficit

-35,598

Equity

16,225

Equity and liabilities

23,563